Classical genotropic versus kinase-initiated regulation of gene transcription by the estrogen receptor α

Endocrinology

Volumn 147, Issue 4, 2006, Pages 1986-1996

  Almeida, M ^a   Han, L ^a   O'Brien, C A ^a   Kousteni, S ^a   Manolagas, S C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; COMPLEMENT COMPONENT C3; CYCLIN D1; DIETHYLSTILBESTROL; EARLY GROWTH RESPONSE FACTOR 1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FRIZZLED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROGESTERONE RECEPTOR; PROTEIN C FOS; PROTEIN KINASE B; WNT2 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME KINETICS; ENZYME PHOSPHORYLATION; ESTROGEN RESPONSIVE ELEMENT; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BINDING SITES; BONE AND BONES; ESTRADIOL; ESTRENES; ESTROGEN RECEPTOR ALPHA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FRIZZLED RECEPTORS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, NEUROTRANSMITTER; TRANSCRIPTION, GENETIC; WNT2 PROTEIN;

EID: 33645509290     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1314     Document Type: Article

References (75)

1. Truss M, Beato M 1993 Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 14:459-479
2. Pfahl M 1993 Nuclear receptor/AP-1 interaction. Endocr Rev 14:651-658
3. Duan R, Porter W, Safe S 1998 Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Endocrinology 139:1981-1990
4. Stein B, Yang MX 1995 Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol Cell Biol 15:4971-4979
5. Li L, Haynes MP, Bender JR 2003 Plasma membrane localization and function of the estrogen receptor variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 100:4807-4812
6. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER 2005 A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630
7. Coiret G, Matifat F, Hague F, Ouadid-Ahidouch H 2005 17-β-estradiol activates maxi-K channels through a non-genomic pathway in human breast cancer cells. FEBS Lett 579:2995-3000
8. Pappas TC, Gametchu B, Watson CS 1995 Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 9:404-410
9. Razandi M, Pedram A, Greene GL, Levin ER 1999 Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 13:307-319
10. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER 2002 ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16:100-115
11. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, Shaul PW 2000 Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 87:E44-E52
12. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR 2000 Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87:677-682
13. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR 2000 Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 97:5930-5935
14. Razandi M, Pedram A, Park ST, Levin ER 2003 Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 278:2701-2712
15. Shaul PW 1999 Rapid activation of endothelial nitric oxide synthase by estrogen. Steroids 64:28-34
16. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW 1999 Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:401-406
17. Chambliss KL, Shaul PW 2002 Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 23:665-686
18. Manolagas SC 2000 Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137
19. Manolagas SC, Kousteni S, Jilka RL 2002 Sex steroids and bone. Recent Prog Horm Res 57:385-409
20. Manolagas SC, Kousteni S, Chen JR, Schuller M, Plotkin L, Bellido T 2004 Kinase-mediated transcription, activators of nongenotropic estrogen-like signaling (ANGELS), and osteoporosis: a different perspective on the HRT dilemma. Kidney Int Suppl S41-S49
21. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han K, DiGregorio G, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730
22. Kousteni S, Han L, Chen J-R, Almeida M, Plotkin LI, Bellido T, Manolagas SC 2003 Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest 111:1651-1664
23. Chen JR, Plotkin LI, Aguirre JI, Han L, Jilka RL, Kousteni S, Bellido T, Manolagas SC 2005 Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens. J Biol Chem 280:4632-4638
24. Kousteni S, Chen J-R, Bellido T, Han L, Ali AA, O'Brien C, Plotkin LI, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfit AM, Weinstein RS, Jilka RL, Manolagas SC 2002 Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298:843-846
25. O'Brien CA, Gubrij I, Lin S-C, Saylors RL, Manolagas SC 1999 STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-κB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone. J Biol Chem 274:19301-19308
26. Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Grignani F, Lanfrancone L, Peschle C, Nolan GP, Pelicci PG 1998 High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res 58:14-19
27. Rai D, Frolova A, Frasor J, Carpenter AE, Katzenellenbogen BS 2005 Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells. Mol Endocrinol 19:1606-1617
28. Duan R, Xie W, Li X, McDougal A, Safe S 2002 Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells. Biochem Biophys Res Commun 294:384-394
29. Chen CC, Lee WR, Safe S 2004 Egr-1 is activated by 17β-estradiol in MCF-7 cells by mitogen-activated protein kinase-dependent phosphorylation of ELK-1. J Cell Biochem 93:1063-1074
30. De Jager T, Pelzer T, Muller-Botz S, Imam A, Muck J, Neyses L 2001 Mechanisms of estrogen receptor action in the myocardium. Rapid gene activation via the ERK1/2 pathway and serum response elements. J Biol Chem 276:27873-27880
31. Katoh M 2003 Expression and regulation of WNT1 in human cancer: up-regulation of WNT1 by β-estradiol in MCF-7 cells. Int J Oncol 22:209-212
32. Katoh M 2001 Differential regulation of WNT2 and WNT2B expression in human cancer. Int J Mol Med 8:657-660
33. Saitoh T, Mine T, Katoh M 2002 Up-regulation of Frizzled-10 (FZD10) by β-estradiol in MCF-7 cells and by retinoic acid in NT2 cells. Int J Oncol 20:117-120
34. Kirikoshi H, Katoh M 2002 Expression and regulation of WNT10B in human cancer: up-regulation of WNT10B in MCF-7 cells by β-estradiol and down-regulation of WNT10B in NT2 cells by retinoic acid. Int J Mol Med 10:507-511
35. Saitoh T, Katoh M 2002 Expression and regulation of WNT5A and WNT5B in human cancer: up-regulation of WNT5A by TNFα in MKN45 cells and up-regulation of WNT5B by β-estradiol in MCF-7 cells. Int J Mol Med 10:345-349
36. Kouzmenko AP, Takeyama K, Ito S, Furutani T, Sawatsubashi S, Maki A, Suzuki E, Kawasaki Y, Akiyama T, Tabata T, Kato S 2004 Wnt/β-catenin and estrogen signaling converge in vivo. J Biol Chem 279:40255-40258
37. Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF 2005 Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression. Int J Oncol 27:949-956
38. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC 2005 Interaction of nuclear receptors with Wnt/β-catenin/Tcf signalling: Wnt you like to know? Endocr Rev 26:898-915
39. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T 1994 Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 269:16433-16442
40. Manolagas SC, Kousteni S 2001 Perspective: nonreproductive sites of action of reproductive hormones. Endocrinology 142:2200-2204
41. Edwards DP 2005 Regulation of signal transduction pathways by estrogen and progesterone. Annu Rev Physiol 67:335-376
42. Revelli A, Massobrio M, Tesarik J 1998 Nongenomic actions of steroid hormones in reproductive tissues. Endocr Rev 19:3-17
43. Losel R, Wehling M 2003 Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 4:46-56
44. Pedram A, Razandi M, Aitkenhead M, Hughes CC, Levin ER 2002 Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem 277:50768-50775
45. Beyer C, Pawlak J, Brito V, Karolczak M, Ivanova T, Kuppers E 2003 Regulation of gene expression in the developing midbrain by estrogen: implication of classical and nonclassical steroid signaling. Ann NY Acad Sci 1007:17-28
46. Duan R, Xie W, Burghardt RC, Safe S 2001 Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J Biol Chem 276:11590-11598
47. Kousteni S, Han L, Almeida M, Chen J-R, Peng H, Jilka RL, Manolagas SC 2003 Induction of osteoblast lineage commitment and differentiation by 4-estren-3α, 17β-diol (estren), but not 17β-estradiol: a putative explanation of the bone anabolic properties of ANGELS. J Bone Miner Res 18:S28
48. Manolagas SC, Kousteni S, Almeida M, Han L, Bellido T, Weinstein RS, O'Brien C, Jilka RL, BMP and Wnt signaling-mediated induction of osteoblast lineage commitment and differentiation by activators of non-genotropic estrogen-like signaling (ANGELS): a novel route to bone anabolism. Program of the 86th Annual Meeting of The Endocrine Society, New Orleans, LA, 2004, p 30 (Abstract S14-3)
49. Dickson RB, Lippman ME 1995 Growth factors in breast cancer. Endocr Rev 16:559-589
50. Clarke R, Skaar TC, Bouker KB, Davis N, Lee YR, Welch JN, Leonessa F 2001 Molecular and pharmacological aspects of antiestrogen resistance. J Steroid Biochem Mol Biol 76:71-84
51. Planas-Silva MD, Weinberg RA 1997 The restriction point and control of cell proliferation. Curr Opin Cell Biol 9:768-772
52. Prall OW, Rogan EM, Sutherland RL 1998 Estrogen regulation of cell cycle progression in breast cancer cells. J Steroid Biochem Mol Biol 65:169-174
53. Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL 1997 Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem 272:10882-10894
54. Sabbah M, Courilleau D, Mester J, Redeuilh G 1999 Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc Natl Acad Sci USA 96:11217-11222
55. Castro-Rivera E, Samudio I, Safe S 2001 Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J Biol Chem 276:30853-30861
56. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price Jr RH, Pestell RG, Kushner PJ 2002 Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J Biol Chem 277:24353-24360
57. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV, Auricchio F 2001 PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 20:6050-6059
58. Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, Levin ER 2003 Identification of a structural determinant necessary for the localization and function of estrogen receptor α at the plasma membrane. Mol Cell Biol 23:1633-1646
59. Wang TT, Phang JM 1995 Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55:2487-2489
60. Teixeira C, Reed JC, Pratt MA 1995 Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55:3902-3907
61. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL 1994 bcl-2 In normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69:135-139
62. Kobayashi S, Iwase H, Ito Y, Yamashita H, Iwata H, Yamashita T, Ito K, Toyama T, Nakamura T, Masaoka A 1997 Clinical significance of bcl-2 gene expression in human breast cancer tissues. Breast Cancer Res Treat 42:173-181
63. Piche A, Grim J, Rancourt C, Gomez-Navarro J, Reed JC, Curiel DT 1998 Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7. Cancer Res 58:2134-2140
64. Perillo B, Sasso A, Abbondanza C, Palumbo G 2000 17β-Estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20:2890-2901
65. Dong L, Wang W, Wang F, Stoner M, Reed JC, Harigai M, Samudio I, Kladde MP, Vyhlidal C, Safe S 1999 Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells. J Biol Chem 274:32099-32107
66. Couse JF, Korach KS 1999 Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20:358-417
67. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90:11162-11166
68. Bocchinfuso WP, Lindzey JK, Hewitt SC, Clark JA, Myers PH, Cooper R, Korach KS 2000 Induction of mammary gland development in estrogen receptor-α knockout mice. Endocrinology 141:2982-2994
69. Jakacka M, Ito M, Martinson F, Ishikawa T, Lee EJ, Jameson JL 2002 An estrogen receptor (ER)α deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol 16:2188-2201
70. Syed F, Modder U, Fraser D, Spelsberg T, Rosen CJ, Krust A, Chambon P, Jameson JL, Khosla S 2005 Skeletal effects of estrogen are mediated by opposing actions of classical and non-classical estrogen receptor pathways. J Bone Miner Res 20:1992-2001
71. Kousteni S, Almeida M, Han L, Warren A, Lowe V, Manolagas SC 2005 Estrogens control the birth and apoptosis of bone cells in mice in which ERa cannot interact with DNA (ERaNerki/-). J Bone Miner Res 20(Suppl 1):S26
72. Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ 2002 Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99:14783-14788
73. Font dM, Brown M 2000 AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 20:5041-5047
74. Wu RC, Qin J, Yi P, Wong J, Tsai SY, Tsai MJ, O'Malley BW 2004 Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic responses to multiple cellular signaling pathways. Mol Cell 15:937-949
75. Park KJ, Krishnan V, O'Malley BW, Yamamoto Y, Gaynor RB 2005 Formation of an IKKα-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol Cell 18:71-82